SYNOPSIS A modification of Salzman's method has been used in an attempt to provide an assay in vitro for the von Willebrand factor. Platelet adhesiveness was increased in von Willebrand's disease by previously coating the beads with normal or haemophilic plasma or cryoprecipitate, whereas von Willebrand plasma had no corrective effect. Antihaemophilic factor (AHF) concentrates were studied in the same way and results compared with experiments in vivo.
Platelet adhesiveness to glass beads as described by Salzman (1963) is a valuable test in the diagnosis of von Willebrand's disease (Strauss and Bloom, 1965; Meyer, Larrieu, Maroteaux, and Caen, 1967b) , although not specific for the disorder.
As suggested by the results of infusion in vivo of normal plasma or fraction 1-0, both the decreased platelet adhesiveness (Salzman, 1963) and the long bleeding time (Nilsson, Blomback, Jorges, Blomback, and Johanson, 1957) may be related to the deficiency of an, as yet unidentified, plasma factor, called 'vascular factor' or 'Willebrand factor'. To examine this possibility further, a modification of Salzman's method has been used in an attempt to provide an in-vitro assay for the Willebrand factor. Data obtained were compared with results of trials in vivo in von Willebrand patients.
Material and Methods
Platelet adhesiveness was measured using Salzman's method (1963) . The time taken for the blood to pass through the glass bead column was kept constant (45 seconds) and results were discarded if the volume of blood collected was not between 5 5 and 6-5 ml. Owing to the slight modifications of the original method (Meyer and Larrieu, 1967a Hershgold, Pool, and Pappenhagen (1966) .
The mean protein, fibrinogen, and factor VIII concentrations are listed in Table I .
Intermediate and high purity AHF concentrates (Johnson, Newman, Howell, and Puszkin, 1967) were kindly provided through the courtesy of Dr Alan Johnson (Table I) A definite increase in platelet adhesiveness was observed with normal (mean 18 %) or haemophilic (mean 15%) plasma, although the results were variable, but coating the beads with Willebrand plasma had no corrective effect (Table II) .
The effect of citrate on platelet adhesiveness was elucidated in control subjects, using glass bead columns previously incubated with normal citrated plasma or citrated buffer. Platelet adhesiveness in the control was only slightly modified by normal citrated plasma (Table III) whereas it was consistently decreased in the presence of citrated buffer.
EFFECT OF NORMAL, HAEMOPHILIC, OR WILLEBRAND CRYO PRECIPITATE
Cryoprecipitates prepared from fresh normal or haemophilic plasma increased platelet adhesiveness to a mean of 25 % and 21 % (Table II) whereas cryoprecipitate from Willebrand plasma was ineffective.
EFFECT OF AHF CONCENTRATES
Intermedite and high purity AHF concentrates were tested in the same way and results were compared with purified albumin or gamma globulin solutions, using the same protein concentration. Both AHF concentrates completely normalized platelet adhesiveness which was not modified in the presence of albumin or gamma globulin (Table IV) .
CONCENTRATION OF THE PROTEINS COATING THE GLASS BEADS
This concentration was measured for the different materials tested. The final protein concentration per millilitre of blood passing through the glass beads was compared with the mean result of platelet adhesiveness for each test material (Table V) (Table VII) .
With both AHF concentrates, factor VIII increased as previously described (Cornu, Larrieu, Caen, and Bernard, 1963) .
Discussion
With respect to certain important technical conditions, platelet adhesiveness to glass beads on whole blood as measured by Salzman (1963) is a useful test in the diagnosis of patients with von Willebrand's disease and of their relatives (Larrieu, Caen, Meyer, Vainer, Sultan, and Bernard, 1968) . Among those technical conditions, the transit speed of blood passing through the glass bead column is the most important to consider, as O'Brien and Heywood (1967) have shown that only a high flow rate will demonstrate an abnormality in von Willebrand's disease. Using a different method in vitro some authors (Zucker, 1963; Salzman and Britten, 1964) have proved the correction of platelet adhesiveness in von Willebrand's disease with normal citrated (Zucker, 1963) or heparinized (Salzman and Britten, 1964) plasma. In these methods, blood from patients with von Willebrand's disease was previously mixed with normal plasma and then passed through a glass bead column. The coating of glass beads with plasma before the test was suggested by Vigliano and Horowitz (1966) for the study of the inhibitory effect of IgA myeloma plasma on platelet adhesiveness.
Plasma proteins, and especially fibrinogen, greatly influence the interaction of platelets with glass surfaces (Packham, Evans, Glynn, and Mustard, 1969) (Larrieu et al, 1968) .
In summary, studies in vitro indicate the existence in normal and haemophilic plasma of a factor, transferable to glass beads and capable of inducing retention of Willebrand platelets by such beads. These results correlating experiments in vivo lend further support to the existence of a plasmatic factor deficiency which is responsible for the decreased platelet adhesiveness characteristic of this disorder.
